期刊
MOLECULAR CANCER
卷 21, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12943-022-01591-z
关键词
NcRNAs; Hedgehog pathway; Cancer; Biomarker; Targeted therapy
资金
- National Natural Science Foundation of China [82073281, 82073884, U20A20413]
- Shenyang ST Projects [19-109-4-09, 20-204-4-22]
This review examines the roles of the Hh pathway and ncRNAs in cancer development and treatment, as well as their crosstalk. ncRNAs related to the Hh pathway can serve as biomarkers for cancer therapy and targets for further research.
Cancer is a type of malignant affliction threatening human health worldwide; however, the molecular mechanism of cancer pathogenesis remains to be elusive. The oncogenic hedgehog (Hh) pathway is a highly evolutionarily conserved signaling pathway in which the hedgehog-Patched complex is internalized to cellular lysosomes for degradation, resulting in the release of Smoothened inhibition and producing downstream intracellular signals. Noncoding RNAs (ncRNAs) with diversified regulatory functions have the potency of controlling cellular processes. Compelling evidence reveals that Hh pathway, ncRNAs, or their crosstalk play complicated roles in the initiation, metastasis, apoptosis and drug resistance of cancer, allowing ncRNAs related to the Hh pathway to serve as clinical biomarkers for targeted cancer therapy. In this review, we attempt to depict the multiple patterns of ncRNAs in the progression of malignant tumors via interactions with the Hh crucial elements in order to better understand the complex regulatory mechanism, and focus on Hh associated ncRNA therapeutics aimed at boosting their application in the clinical setting.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据